According to Quotient's latest financial reports the company's current earnings are S$37.41 Million. In 2021 the company made an earning of -S$0.14 Billion a decrease over its 2020 earnings that were of -S$89.82 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | -S$0.13 Billion | -10.55% |
2021 | -S$0.14 Billion | 54.74% |
2020 | -S$89.82 Million | -11.48% |
2019 | -S$0.11 Billion | -2.94% |
2018 | -S$0.11 Billion | 20.2% |
2017 | -S$86.97 Million | 1.47% |
2016 | -S$85.71 Million | 188.24% |
2015 | -S$29.74 Million | -61.35% |
2014 | -S$76.93 Million | 905.28% |
2013 | -S$7.66 Million |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Chembio Diagnostics CEMI | -S$30.19 Million | -73.59% | ๐บ๐ธ USA |
![]() Eterna Therapeutics ERNA | -S$44.59 Million | -60.99% | ๐บ๐ธ USA |
![]() Atossa Therapeutics ATOS | -S$33.92 Million | -70.33% | ๐บ๐ธ USA |